Amundi Asset Management US’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$523K Sell
2,411
-489
-17% -$91.9K ﹤0.01% 1319
2020
Q4
$335K Hold
2,900
﹤0.01% 1360
2020
Q3
$282K Sell
2,900
-100
-3% -$11.5K ﹤0.01% 1332
2020
Q2
$368K Hold
3,000
﹤0.01% 1295
2020
Q1
$263K Hold
3,000
﹤0.01% 1288
2019
Q4
$314K Hold
3,000
﹤0.01% 1394
2019
Q3
$345K Buy
3,000
+700
+30% +$106K ﹤0.01% 1376
2019
Q2
$396K Hold
2,300
﹤0.01% 1385
2019
Q1
$388K Hold
2,300
﹤0.01% 1343
2018
Q4
$224 Buy
2,300
+800
+53% +$105K ﹤0.01% 1375
2018
Q3
$259K Hold
1,500
﹤0.01% 1436
2018
Q2
$209K Buy
1,500
+200
+15% +$28.4K ﹤0.01% 1415
2018
Q1
$146K Buy
1,300
+800
+160% +$101K ﹤0.01% 1378
2017
Q4
$66K Buy
+500
New +$58.8K ﹤0.01% 1475

Other funds holding GWPH

Amundi Asset Management US's GWPH Position: Q1 2021 in Review

Amundi Asset Management US reduced its GW Pharmaceuticals Plc American Depositary Shares (GWPH) stake by 17% in Q1 2021, selling an estimated $91.9K and leaving 2,411 shares worth $523K. The position accounts for ﹤0.01% of the portfolio, ranked #1319.

Amundi Asset Management US first reported a position in GWPH in Q4 2017 and has held it in 14 quarters since. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

  • Amundi Asset Management US held 2,411 shares of GW Pharmaceuticals Plc American Depositary Shares worth $523K as of Q1 2021.
  • Amundi Asset Management US sold 489 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $91.9K.
  • GW Pharmaceuticals Plc American Depositary Shares made up ﹤0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #1319 holding.
  • Amundi Asset Management US first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2017 and has held it in 14 quarters since.
  • 297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.